Thomas C. Boone

Keine laufenden Positionen mehr

Health Technology

Consumer Services

Profil

Thomas C.
Boone worked as a Senior Vice President of Protein Sciences at Oxford BioTherapeutics Ltd., Vice President of Protein Sciences at Amgen, Inc., and Vice President of Preclinical Research & Development at Zymeworks BC, Inc. He obtained undergraduate degrees from the University of California, Los Angeles and the University of California, Davis.

Ehemalige bekannte Positionen von Thomas C. Boone

Unternehmen	Position	Ende
AMGEN INC.	Corporate Officer/Principal	-
Zymeworks BC, Inc. Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada.	Technik-/Wissenschafts-/F&E-Leiter	-
Oxford BioTherapeutics Ltd. Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom.	Corporate Officer/Principal	-

Sehen Sie sich die Erfahrung von Thomas C. Boone im Detail an

Ausbildung von Thomas C. Boone

University of California, Davis	Undergraduate Degree
University of California, Los Angeles	Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen